BDNF and schizophrenia: Given these facts, the findings showing an increase in the proportion of D1-D2 heteromers in high affinity state in both schizophrenia and chronic amphetamine treatment may indicate a preponderant role of the D1-D2 receptor heteromer-mediated calcium-CaMKII-BDNF signaling pathway in both drug addiction and schizophrenia.